A Study of Breath Testing for Small Intestinal Bacterial Overgrowth
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMayo Clinic
About this trial
Researchers hope to determine how often small intestinal bacterial overgrowth occurs after taking proton pump inhibitors.
Eligibility criteria
Qualifiers
Predominant symptoms of gastroesophageal reflux disease including heartburn, regurgitation
Subjects must be able to give appropriate informed consent
Disqualifiers
Prior diagnosis of SIBO
Use of PPIs or H2R-anatagonstists in the prior 3 months
Major concomitant illness (renal, hepatic, rheumatologic or cardiovascular disease, or malignancy)
Antibiotic therapy within one month
Trial design
Treatments tested in this trial
- Breath Testing
Treatment groups
50 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov